BIOMAT Database Logo BIOMAT Database Logo

Comparison of three methods for cyclosporine therapeutic monitoring. 2007

N Jebabli, and A Klouz, and A Bahlous, and E Gaïes, and S Trabelsi, and M Lakhal, and C Belkahia
Centre National de Pharmacovigilance, Laboratoire de Pharmacologie Clinique, Hôpital Charles Nicolle, 9 Rue Dr Zouheir Assafi, 1006 Tunis, Tunisia.

Cyclosporine (CsA) is an immunosuppressive drug used extensively in human transplants of solid organs or bone marrow as well as in the treatment of autoimmune diseases. To optimize immunosuppressive efficacy and minimize adverse reactions, blood CsA concentrations are monitored to allow appropriate dosage adjustments. To establish objective criteria to compare various techniques of CsA monitoring, we performed a detailed study over 5 months to compare and evaluate three immunoassays methods in comparison to the reference method of high-performance liquid chromatography (HPLC). Our study included 976 samples that were evaluated by: the COBAS INTEGRA 800 (Roche Laboratories); the V-Twin (Dade Behring Laboratories); and the AxSYM FPIA (Abbott Laboratories). Our results showed that all of the immunoassays yielded slightly higher concentrations than HPLC. However CsA concentrations obtained by AxSYM were most close to those of HPLC, so that this method seemed to be more specific than the other two.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D002138 Calibration Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. Calibrations
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004784 Environmental Monitoring The monitoring of the level of toxins, chemical pollutants, microbial contaminants, or other harmful substances in the environment (soil, air, and water), workplace, or in the bodies of people and animals present in that environment. Monitoring, Environmental,Environmental Surveillance,Surveillance, Environmental
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

N Jebabli, and A Klouz, and A Bahlous, and E Gaïes, and S Trabelsi, and M Lakhal, and C Belkahia
Comparison of three methods for cyclosporine area under the curve monitoring calculations.
June 1995, Therapeutic drug monitoring,
N Jebabli, and A Klouz, and A Bahlous, and E Gaïes, and S Trabelsi, and M Lakhal, and C Belkahia
Therapeutic monitoring of cyclosporine.
January 1994, Annals of clinical and laboratory science,
N Jebabli, and A Klouz, and A Bahlous, and E Gaïes, and S Trabelsi, and M Lakhal, and C Belkahia
Therapeutic cyclosporine monitoring: comparison of radioimmunoassay and high-performance liquid chromatography methods in organ transplant recipients.
July 1990, Therapeutic drug monitoring,
N Jebabli, and A Klouz, and A Bahlous, and E Gaïes, and S Trabelsi, and M Lakhal, and C Belkahia
Cyclosporine therapeutic drug monitoring.
September 2001, Transplantation proceedings,
N Jebabli, and A Klouz, and A Bahlous, and E Gaïes, and S Trabelsi, and M Lakhal, and C Belkahia
Therapeutic drug monitoring of cyclosporine.
August 1984, Mayo Clinic proceedings,
N Jebabli, and A Klouz, and A Bahlous, and E Gaïes, and S Trabelsi, and M Lakhal, and C Belkahia
[Therapeutic monitoring of cyclosporine A].
July 2002, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
N Jebabli, and A Klouz, and A Bahlous, and E Gaïes, and S Trabelsi, and M Lakhal, and C Belkahia
Therapeutic drug monitoring of cyclosporine.
March 2004, Transplantation proceedings,
N Jebabli, and A Klouz, and A Bahlous, and E Gaïes, and S Trabelsi, and M Lakhal, and C Belkahia
Therapeutic drug monitoring of cyclosporine.
March 2004, Transplantation proceedings,
N Jebabli, and A Klouz, and A Bahlous, and E Gaïes, and S Trabelsi, and M Lakhal, and C Belkahia
Comparison of Two Analytical Methods for Busulfan Therapeutic Drug Monitoring.
January 2021, European journal of drug metabolism and pharmacokinetics,
N Jebabli, and A Klouz, and A Bahlous, and E Gaïes, and S Trabelsi, and M Lakhal, and C Belkahia
Steady-state concentrations of cyclosporine for therapeutic monitoring.
June 1990, Transplantation proceedings,
Copied contents to your clipboard!